Representativeness of European clinical trial populations in mild Alzheimer’s disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study

BACKGROUND: Comparison of disease progression between placebo-group patients from randomised controlled trials (RCTs) and real-world patients can aid in assessing the generalisability of RCT outcomes. This analysis compared outcomes between community-dwelling patients with mild Alzheimer’s disease (...

Descripción completa

Detalles Bibliográficos
Autores principales: Reed, Catherine, Belger, Mark, Dell’Agnello, Grazia, Kahle-Wrobleski, Kristin, Sethuraman, Gopalan, Hake, Ann, Raskin, Joel, Henley, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883304/
https://www.ncbi.nlm.nih.gov/pubmed/29615123
http://dx.doi.org/10.1186/s13195-018-0360-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883304/
https://www.ncbi.nlm.nih.gov/pubmed/29615123
http://dx.doi.org/10.1186/s13195-018-0360-4

Ejemplares similares